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ABSTRACT 
Context: Cyanide poisoning may be caused by acetonitrile, a common industrial organic solvent and 
laboratory agent. 
Objective: To describe the potential use of disulfiram in treating acetonitrile poisoning in a human 
clinical case and to further study its effect in human liver microsomes in vitro. 
Case details: A 30-year-old man initially presented with a cholinergic toxic syndrome following 
ingestion of aldicarb. Toxicological analysis revealed coingestion of ethanol. He subsequently 
developed severe metabolic acidosis caused by the cyanogenic compound acetonitrile which was 
erroneously interpreted as acetone in the chromatogram. After 3 treatments with hydroxocobalamin 
(5g i.v.) and sodium thiosulfate (12.5g i.v.) on days 2, 3 and 5, he had transient improvement but 
recurrent lactic acidosis. Treatment with disulfiram was associated on day 7 with resolution of 
metabolic acidosis and slowing of the decrease in acetonitrile concentration. He recovered from 
acetonitrile toxicity completely. The time course of acetonitrile, thiocyanate, and cyanide 
concentrations suggested that disulfiram inhibited cyanide formation.  
Results: In vitro experiments with human liver microsomes showed the cyanide concentration was 
significantly lower after incubation with acetonitrile and disulfiram than acetonitrile alone (a mean 
60% reduction in cyanide level). 
Discussion: Although disulfiram was given late in the course of the poisoning it is possible that it 
contributed to the recovery. 
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INTRODUCTION 
Cyanide poisoning may be caused by acetonitrile, a common industrial organic solvent and 
laboratory agent that has been used in cosmetic nail polish remover. Previous reports of acetonitrile 
intoxication after inhalation or oral ingestion in 23 patients have included 8 deaths.1,2 Acetonitrile 
initially is slowly metabolized by cytochrome P450 2E1 (CYP2E1) to cyanohydrin, which is broken 
down by catalase to form cyanide and formaldehyde (Figure 1).3 Cyanide may be transformed by 
rhodanese to the less toxic thiocyanate, but this reaction may be delayed by the depletion of 
substrates such as thiosulfate necessary for this reaction.1 Cyanide also may be neutralized by 
binding to dicobalt edetate or reaction with hydroxocobalamin (Figure 1). 
 Acetonitrile poisoning has been treated with sodium thiosulfate alone or varied 
combinations of dicobalt edetate, hydroxocobalamin, sodium nitrite, amyl nitrite, and 4-
dimethylaminopyridine.1,2 Literature review showed no previous reports of treatment of acetonitrile 
poisoning with the combination of hydroxocobalamin and sodium thiosulfate. We treated a patient 
who initially presented with a cholinergic toxic syndrome following ingestion of aldicarb and who 
subsequently developed severe metabolic acidosis due to cyanide poisoning by acetonitrile 
coingestion. The protracted clinical course with recurrent lactic acidosis required treatment with the 
combination of hydroxocobalamin and sodium thiosulfate on days 2, 3 and 5. This was supplemented 
with disulfiram on day 7 since we hypothesized that disulfiram may inhibit CYP2E1-mediated 
toxification of acetonitrile.
CASE DETAILS 
 A 30-year-old male technician was found comatose in his laboratory. A mobile intensive care 
unit team diagnosed a cholinergic toxic syndrome. Blood glucose level was normal and oxygen 
saturation on room air was 89%. The patient was intubated and atropine (3.5 mg) was given 
intravenously. Broken bottles with chemicals were found at the scene, and a witness saw him 
ingesting aldicarb 30 minutes earlier.  
 After arrival at the emergency department, treatment included gastric lavage, activated 
charcoal (via an orogastric tube), atropine (2 mg/h i.v.), and pralidoxime (30 mg/kg once, then 8 
mg/kg/h i.v.). Past medical history included previous episodes of self-intoxication with methanol and 
heavy tobacco use.  
Laboratory test results at admission were as follows: red blood cells 5.30 × 106/µL (normal range: 
4.35–5.87 × 106/µL), white blood cells 10.76 × 103/µL (normal range: 4–10 × 103/µL), thrombocytes 
291 × 103/µL (normal range: 136–356 × 103/µL), serum creatinine 81 μmol/L (normal range: 64–103 
μmol/L), urea 0.16 g/L (normal range: 0.13–0.43 g/L), glucose 8.2 mmol/L (normal range: 4.0-5.9 
mmol/L), sodium 142 mmol/L (normal range: 135-144 mmol/L), potassium 3.2 mmol/L (normal 
range: 3.6-4.8 mmol/L), chloride 103 mmol/L (normal range: 98-106 mmol/L), calcium 8.9 mg/dL 
(normal range: 8.5-10.5 mg/dL), aspartame aminotransferase (ASAT) 17 UI/L (normal range: 0–37 
U/L), alanine aminotransferase (ALAT) 15 U/L (normal range: 7–40 UI/L), gamma-glutamyltransferase 
17 UI/L (normal range: 12-64 UI/L), lipase 66 UI/L (normal range: 0-60). Hemostasis parameters were 
as follows: prothrombin time 80 % (normal range: 70-120 %), index normalized ratio (INR) 1.17 
(normal range: 0.9-1.1), fibrinogen 325 mg/dL (normal range: 200–400 mg/dL). Initial blood gas 
showed pH of 7.40 (normal range: 7.35-7.45), pCO2 of 34.1 mmHg (normal range: 35-45 mmHg), pO2 
of 244 mmHg (normal range: 83-108 mmHg), HCO3 of 20 mmol/L (normal range: 22-26 mmol/L), base 
excess of -3.6 mmol/L (normal range: -2-+3 mmol/L) and lactate 2.3 mmol/L (normal range: 0.5-2.2 
mmol/L).  
Ethanol level was 2.3 g/L; osmolal gap was high (31 mOsm/kg after correction for ethanol); and blood 
cholinesterase activity was low (3920 U/L; normal range, 11188 to 16698 U/L). Fomepizole treatment 
was not initiated because the criteria for toxic alcohol treatment were not met and the ethanol blood 
level was well above the therapeutic range for treatment of toxic alcohols.  
Toxicology blood screening was negative for tricyclic antidepressants, salicylates, paracetamol, 
benzodiazepines, barbiturates, phenothiazines, opioids. Gas chromatography-mass spectrometry 
showed the presence of venlafaxine. The presence of methanol and ethylene glycol in blood was 
excluded with gas chromatography with flame ionization and gas chromatography-mass 
spectrometry respectively. Urine toxicology testing was negative for paraquat and para nitrophenol. 
Gas chromatography with flame ionization suggested that the elevated osmolal gap was caused by 
acetone. 
 The cholinergic crisis subsided and the patient was extubated 10 hours after admission. 
However, he developed agitation and severe lactic acidosis 12 hours later necessitating reintubation 
(Figure 2). After typical causes of lactic acidosis were ruled out, poisoning with a cyanogenic 
compound was considered, and the patient was treated with hydroxocobalamin (5 g i.v.) and sodium 
thiosulfate (12.5 g i.v.) (Figure 2). This caused prompt clinical improvement and decrease in plasma 
lactate level, and he was extubated. The analytical toxicologist reinspected the chromatogram and 
suspected that acetonitrile had been mistaken for acetone. Injection of a standard of acetonitrile in 
the gas chromatography with flame ionization revealed that the retention time of the standard 
corresponded completely with that of the peak in the patient sample that was first erroneously 
reported as acetone. The concentrations of blood cyanide and plasma thiocyanate were determined 
by a colorimetric method4,5 and the plasma acetonitrile was determined by headspace gas 
chromatography (Figure 2).  
 The patient had relapsing lactic acidosis, and treatment with hydroxocobalamin (5 g i.v.) and 
sodium thiosulfate (12.5 g i.v.) was repeated 2 more times (Figure 2). On the 7th day, thiocyanate 
levels remained high and lactate level increased again. After disulfiram was given (400 mg oral), the 
metabolic acidosis resolved and the decrease in acetonitrile concentration slowed (Figure 2). The 
patient recovered completely, received psychiatric care, and informed the health care providers that 
he had ingested acetonitrile with aldicarb in a suicide attempt and informed us that he was familiar 
with their toxic effects. He gave deferred informed consent for disulfiram treatment and blood 
sampling. 
 This case suggested that disulfiram was a useful antidote for acetonitrile poisoning. 
Therefore, the effect of disulfiram was evaluated in human liver microsomes in vitro. Human liver 
microsomes (BD UltraPool, BD Biosciences, Billerica, MA) were incubated with acetonitrile (600 mM) 
and the effect of disulfiram (1.35 µM) was studied using a modification of a previously described 
protocol.6 Cyanide was measured as previously described.7 The concentration of disulfiram used 
corresponded with free plasma concentration in humans. On 3 different days, experiments were 
performed with 18 samples (9 samples with and 9 samples without disulfiram). The mean cyanide 
concentration was significantly lower after incubation with acetonitrile and disulfiram (mean ± SD; 4 
± 3 μM) than acetonitrile alone (10 ± 3 μM; one-sided t test, P ≤ .001); disulfiram caused a mean 60% 
reduction in cyanide level (Figure 3). 
DISCUSSION 
 The patient presented with a cholinergic toxic syndrome and developed severe metabolic 
acidosis that was caused by acetonitrile and that responded temporarily to repeated administration 
of hydroxocobalamin and sodium thiosulfate. After relapse of metabolic acidosis, treatment with 
disulfiram caused a slowing of cyanide production and resolution of the toxic syndrome.  
 A high index of suspicion is necessary in treating patients who have acute poisoning. In the 
present patient, the elevated osmolal gap was initially attributed to acetone but later shown to be 
caused by acetonitrile. Misdiagnosis because of close retention times between different substances 
on chromatography has been reported previously.1,8 Acetonitrile intoxication might have been 
suspected earlier if accurate information had been available about substances present at the scene 
of the poisoning. In addition, a high index of suspicion is necessary with a clinical course that is 
atypical for the suspected toxic substance, and multiple substances may be used in self intoxication. 
In this case, the suspicion about the presence of a second substance occurred from routinely 
available tests used to evaluate and monitor acute poisoning, including the osmolal gap, blood gases, 
and lactate level.  
 The clinical course was remarkable for the delayed onset of symptoms. After acetonitrile 
exposure, patients typically remain well for several hours before developing signs of cyanide 
poisoning. This delay may be explained by the metabolism of acetonitrile, which is broken down by 
CYP2E1 and catalase to form cyanide (Figure 1).6,9 In addition, ethanol may prevent toxicity of nitriles 
by inhibiting the formation of cyanide.10 This may be attributed to competition between ethanol and 
acetonitrile for CYP2E1 and competition between ethanol and cyanohydrin for peroxidation by 
catalase (Figure 1).6 The prolonged delay in the development of symptoms in the present patient (24 
hours) compared with other cases (3 to 12 hours)1,2 may have occurred because of ethanol. 
 The present case illustrates the importance of understanding the mechanism of toxicity, 
especially because some poisonings from toxins such as acetonitrile are rare with limited previous 
reports. The combination of hydroxocobalamin and sodium thiosulfate is based on the neutralization 
of cyanide by binding to hydroxocobalamin to form cyanocobalamin and the conversion of cyanide 
and thiosulfate to thiocyanate, catalyzed by rhodanese (Figure 1). The combination of these 2 
antidotes is beneficial because they have negligible adverse effects and they are the antidotes of 
choice for cyanide poisoning.11,12 The same combination has been used successfully in a patient after 
severe poisoning with propionitrile, another cyanogenic compound.13 The duration of antidote 
treatment should be sufficiently long because of the slow elimination of acetonitrile.2 The need for 
repeated administration of antidote for 5 days after acetonitrile poisoning has been previously 
reported, but time course may vary (Figure 2).1,2  
 Disulfiram has been proposed as an inhibitor of CYP2E1-mediated toxification of volatile 
solvents.14 Before administration of disulfiram, bicarbonate levels decreased, which suggested 
ongoing formation of cyanide and/or of formate which unfortunately was not analyzed (Figure 2).  
Disulfiram is a strong inhibitor of CYP2E1 in humans and may be useful in treating halothane toxicity 
mediated by CYP2E1 and toxicity from industrial solvents (Figure 1).14-16 The disulfiram-mediated 
decrease in acetonitrile metabolism was less harmful than the formation of cyanide because 
nonmetabolized acetonitrile itself has little toxicity.17 Disulfiram is contraindicated in patients who 
are simultaneously poisoned with ethanol and acetonitrile, but fomepizole may be considered for 
treatment of disulfiram-ethanol reactions.18 In the present patient, disulfiram was used more than 6 
days after exposure to acetonitrile and ethanol, and the elevated ethanol level presumably had 
resolved. 
 Although disulfiram was given late in the course of the poisoning and following treatment 
with gastric decontamination, hydroxocobalamin and thiosulfate treatment and supportive critical 
care, it is possible that disulfiram contributed to the revovery. This was suggested by the 
improvement of bicarbonate and lactate levels and the time course of acetonitrile, thiocyanate, and 
cyanide concentrations. After administration of disulfiram, the decrease in acetonitrile concentration 
became slowed for approximately 50 hours (Figure 2), suggesting that disulfiram inhibited 
acetonitrile metabolism by inhibition of CYP2E1 (Figure 1).14,16 The decreased acetonitrile elimination 
was accompanied by a log-linear decline in thiocyanate concentration, which was faster than the 
decline in the concentration of the parent compound acetonitrile (Figure 2). This is evidence that 
disulfiram may inhibit acetonitrile metabolism as under normal conditions (i.e. without inhibition of 
metabolite formation), the half-life of a metabolite may only equal or even exceed the half-life of the 
parent compound. Subsequently, thiocyanate elimination became slower, possibly because of a 
decrease in the inhibitory effect of disulfiram. The fact that the acetonitrile concentrations still 
decreased after the inhibition may be explained by other elimination pathways.  
 In the present patient, the high thiocyanate level on admission may be attributed to heavy 
tobacco use, and the initial decrease may have been caused by smoking cessation after acetonitrile 
ingestion (Figure 2).19 The cyanide level had a fluctuating pattern, possibly because of the temporary 
effect of hydroxocobalamin and sodium thiosulfate. After disulfiram administration, cyanide levels 
decreased unequivocally (Figure 2).  
 The decreased cyanide formation observed in the in vitro experiment using human liver 
microsomes supported the therapeutic potential of disulfiram in acetonitrile intoxication. The 
acetonitrile concentration in the in vitro experiment was in excess of acetonitrile levels observed in 
humans. High concentrations of acetonitrile were used because of the high detection limit of 
cyanide. Therefore, the findings may have underestimated the in vivo effect of disulfiram on 
acetonitrile metabolism. Furthermore, the potential role of disulfiram metabolites in CYP2E1 
inhibition was not evaluated. However, the in vitro findings are consistent with in vivo human 
observations after administration of disulfiram, including a reduction in CYP2E1 activity by 90% and a 
reduction in CYP2E1-mediated halothane metabolism by 85%.14,16 
 The maximum cyanide level in the present patient (30 μg/mL) exceeded the highest value 
previously reported in acetonitrile poisoning (17 μg/mL).1 Although cyanide blood levels > 3 μg/mL 
are considered potentially lethal, the patient survived.20 Previous studies in mice suggested that 
there is no relation between blood cyanide level and lethality, and brain (not blood) cyanide levels 
may be the best indicator of lethality.3,21 Nevertheless, there may be large overlap of cyanide blood 
levels between patients who survive or die after acetonitrile exposure.1,2  
 The present case demonstrates the importance of considering the mechanism of toxicity 
during treatment of suspected poisoning. When the clinical course is atypical, the involvement of 
substances other than the primary toxin should be considered. In clinical toxicology, well-designed 
clinical studies usually are unavailable and case reports frequently are the only source of clinical 
information. In vitro studies may provide additional insight into the treatment of uncommon 
intoxications. The present clinical and in vitro observations suggest that disulfiram may be a useful 
antidote in treating delayed cyanide poisoning after acetonitrile intoxication, possibly by inhibiting 
CYP2E1-mediated metabolism of acetonitrile. 
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FIGURES 
Figure 1. Metabolism of acetonitrile and cyanide. 
 
 
 
Figure 2. A 30-year-old man who had cyanide poisoning after ingestion of acetonitrile. Panel A shows 
the time course of concentrations of lactate and bicarbonate, and panel B shows the time course of 
acetonitrile, cyanide, and thiocyanate. The patient was treated with 3 doses of hydroxocobalamin (5 
g i.v.) and thiosulfate (12.5 g i.v.) (open arrows) and 1 dose of disulfiram (400 mg oral) (filled arrow).  
 
Figure 3. Results of the incubation experiments carried out in triplicate on three different days (n=9). 
Concentrations of acetonitrile and disulfiram added to the final incubate were 600 mM and 1.35 µM 
respectively.   
  
 
